Changes in choline metabolism as potential biomarkers of phospholipase Cγ1 inhibition in human prostate cancer cells

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Molecular Cancer Therapeutics

• Publication date

  2009-05-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1158/1535-7163.MCT-09-0039PMID 19417158
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PTEN: a new guardian of the genome

  2008cited by this paper
• Thematic Review Series: Sphingolipids. Nuclear sphingolipids: metabolism and signaling** This study was supported by National Institutes of Health grant 2RO1 NS033912. Published, JLR Papers in Press, March 9, 2008.

  2008cited by this paper
• Phospholipase Cgamma1 is required for metastasis development and progression.

  2008cited by this paper
• Phospholipase Cγ1 regulates the Rap GEF1-Rap1 signalling axis in the control of human prostate carcinoma cell adhesion

  2008cited by this paper
• Combined Inhibition of PLCγ-1 and c-Src Abrogates Epidermal Growth Factor Receptor–Mediated Head and Neck Squamous Cell Carcinoma Invasion

  2008cited by this paper
• Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of a novel histone deacetylase inhibitor, LAQ824, in human colon carcinoma cells and xenografts.

  2008cited by this paper
• PLCγ contributes to metastasis of in situ-occurring mammary and prostate tumors

  2007cited by this paper
• Anti-inflammatory agent indomethacin reduces invasion and alters metabolism in a human breast cancer cell line.

  2007cited by this paper
• NMR-based metabolomics: translational application and treatment of cancer.

  2007cited by this paper
• PLC gamma contributes to metastasis of in situ-occurring mammary and prostate tumors.

  2007cited by this paper
• In vivo proton magnetic resonance spectroscopy of breast lesions: an update

  2007cited by this paper
• Cancer metastasis: building a framework.

  2006cited by this paper
• Benzoquinone ansamycin heat shock protein 90 inhibitors modulate multiple functions required for tumor angiogenesis

  2006cited by this paper
• Identification of magnetic resonance detectable metabolic changes associated with inhibition of phosphoinositide 3-kinase signaling in human breast cancer cells

  2006cited by this paper
• Signal transduction via vascular endothelial growth factor (VEGF) receptors and their roles in atherogenesis.

  2006influential reference
• Choline metabolism in cancer: implications for diagnosis and therapy

  2006cited by this paper
• Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions.

  2006cited by this paper
• Minimally invasive pharmacokinetic and pharmacodynamic technologies in hypothesis-testing clinical trials of innovative therapies.

  2006cited by this paper
• Mechanisms of indomethacin-induced alterations in the choline phospholipid metabolism of breast cancer cells.

  2006cited by this paper
• Detection of histone deacetylase inhibition by noninvasive magnetic resonance spectroscopy

  2006cited by this paper
• PLCγ1 is essential for early events in integrin signalling required for cell motility

  2005cited by this paper
• Alterations of choline phospholipid metabolism in ovarian tumor progression.

  2005cited by this paper
• 1H-NMR metabolic markers of malignancy correlate with spontaneous metastases in a murine mammary tumor model.

  2005cited by this paper
• Magnetic resonance spectroscopy monitoring of mitogen-activated protein kinase signaling inhibition.

  2005cited by this paper
• Targeting key steps in metastatic tumour progression.

  2005cited by this paper
• Imatinib (STI571)-Mediated Changes in Glucose Metabolism in Human Leukemia BCR-ABL-Positive Cells

  2004cited by this paper
• Molecular Causes of the Aberrant Choline Phospholipid Metabolism in Breast Cancer

  2004cited by this paper
• How much gets there and what does it do?: The need for better pharmacokinetic and pharmacodynamic endpoints in contemporary drug discovery and development.

  2003cited by this paper
• Magnetic resonance spectroscopic pharmacodynamic markers of the heat shock protein 90 inhibitor 17-allylamino,17-demethoxygeldanamycin (17AAG) in human colon cancer models.

  2003cited by this paper
• Phospholipase C-γ1 in tumor progression

  2003cited by this paper
• Phospholipase C-gamma1 in tumor progression.

  2003cited by this paper
• Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis.

  2002cited by this paper
• Regulation of choline kinase activity by Ras proteins involves Ral–GDS and PI3K

  2002cited by this paper
• Challenges of PK/PD measurements in modern drug development.

  2002cited by this paper
• Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells.

  2001cited by this paper
• Magnetic resonance detects changes in phosphocholine associated with Ras activation and inhibition in NIH 3T3 cells

  2001cited by this paper
• PTEN: life as a tumor suppressor.

  2001cited by this paper
• Mechanism-based target identification and drug discovery in cancer research.

  2000cited by this paper
• Tumor invasion: role of growth factor-induced cell motility.

  2000cited by this paper
• Anticancer drug targets: growth factors and growth factor signaling.

  2000cited by this paper
• Overexpression of phospholipase C-gamma1 suppresses UVC-induced apoptosis through inhibition of c-fos accumulation and c-Jun N-terminal kinase activation in PC12 cells.

  1999cited by this paper
• Tumour phospholipid metabolism

  1999cited by this paper
• Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells.

  1999cited by this paper
• A role for phospholipase C-gamma-mediated signaling in tumor cell invasion.

  1999cited by this paper
• Shaping up for shipping out: PLCgamma signaling of morphology changes in EGF-stimulated fibroblast migration.

  1999cited by this paper
• Nm23‐transfected MDA‐mB‐435 human breast carcinoma cells form tumors with altered phospholipid metabolism and pH: A 31P nuclear magnetic resonance study in vivo and in vitro

  1999cited by this paper
• A Role for Phospholipase C-γ-mediated Signaling in Tumor Cell Invasion

  1999cited by this paper
• Measurements of human breast cancer using magnetic resonance spectroscopy: a review of clinical measurements and a report of localized 31P measurements of response to treatment

  1998cited by this paper
• Two distinct phospholipases C of Listeria monocytogenes induce ceramide generation, nuclear factor-kappa B activation, and E-selectin expression in human endothelial cells.

  1998cited by this paper
• Growth inhibition by phospholipase C inhibitor peptides of colorectal carcinoma cells derived from familial adenomatous polyposis.

  1996cited by this paper
• Kinetics of choline transport and phosphorylation in human breast cancer cells; NMR application of the zero trans method.

  1996cited by this paper
• Generation of phosphorylcholine as an essential event in the activation of Raf‐1 and MAP‐kinases in growth factors‐induced mitogenic stimulation

  1995cited by this paper
• Overexpression of phospholipase C-gamma 1 in familial adenomatous polyposis.

  1994cited by this paper
• Overexpression of Phospholipase C-γ1 in Familial Adenomatous Polyposis

  1994cited by this paper
• Phosphorylcholine: a novel second messenger essential for mitogenic activity of growth factors.

  1993cited by this paper
• In vivo 31P MRS of experimental tumours

  1993cited by this paper
• Hydrolysis of phosphatidylcholine is stimulated by Ras proteins during mitogenic signal transduction

  1992cited by this paper
• Studies of human tumors by MRS: A review

  1992cited by this paper
• Phospholipase C-mediated hydrolysis of phosphatidylcholine is an important step in PDGF-stimulated DNA synthesis.

  1990cited by this paper

• Phosphatidylcholine-Derived Lipid Mediators: The Crosstalk Between Cancer Cells and Immune Cells

  2022cites this paper
• Recent advances in understanding the molecular role of phosphoinositide-specific phospholipase C gamma 1 as an emerging onco-driver and novel therapeutic target in human carcinogenesis.

  2021cites this paper
• Phosphoinositide specific phospholipase Cγ1 inhibition-driven autophagy caused cell death in human lung adenocarcinoma A549 cells in vivo and in vitro

  2020cites this paper
• Computational Tools for the Untargeted Assignment of FT-MS Metabolomics Datasets

  2019cites this paper
• Molecular Effects of Doxorubicin on Choline Metabolism in Breast Cancer

  2017cites this paper
• The fast Padé transform for noisy magnetic resonance spectroscopic data from the prostate: potential contribution to individualized prostate cancer care

  2016cites this paper
• Improved specificity of serum phosphatidylcholine detection based on side-chain losses during negative electrospray ionization tandem mass spectrometry

  2016cites this paper
• Characterization of ADAMTS-15: a potential tumor suppressor gene in prostate cancer.

  2016cites this paper
• Lentivirus-mediated PLCγ1 gene short-hairpin RNA suppresses tumor growth and metastasis of human gastric adenocarcinoma

  2016cites this paper
• DAG/PKCδ and IP3/Ca2+/CaMK IIβ Operate in Parallel to Each Other in PLCγ1-Driven Cell Proliferation and Migration of Human Gastric Adenocarcinoma Cells, through Akt/mTOR/S6 Pathway

  2015cites this paper
• WISP-2 in human gastric cancer and its potential metastatic suppressor role in gastric cancer cells mediated by JNK and PLC-γ pathways

  2015cites this paper
• The effect of a thieno[2,3- b ]pyridine PLC-γ inhibitor on the proliferation, morphology, migration and cell cycle of breast cancer cells

  2014cites this paper
• Metastasis of human gastric adenocarcinoma partly depends on phosphoinositide-specific phospholipase γ1 expression.

  2014cites this paper
• NMR-Based Metabolic Profiling: Methods and Application in Cancer Biomarker Discovery.

  2014cites this paper
• Magic angle spinning NMR spectroscopic metabolic profiling of gall bladder tissues for differentiating malignant from benign disease

  2013cites this paper
• Phospholipase C-γ1 expression correlated with cancer progression of potentially malignant oral lesions.

  2013cites this paper
• The role of choline in prostate cancer.

  2012cites this paper
• Histone deacetylase inhibition increases levels of choline kinase α and phosphocholine facilitating noninvasive imaging in human cancers.

  2012cites this paper
• Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells

  2012cites this paper
• MR evaluation of response to targeted treatment in cancer cells

  2011cites this paper
• Magnetic Resonance Spectroscopy Detectable Metabolomic Fingerprint of Response to Antineoplastic Treatment

  2011cites this paper
• Human prostate cell lines from normal and tumourigenic epithelia differ in the pattern and control of choline lipid headgroups released into the medium on stimulation of protein kinase C

  2011cites this paper
• A hyperpolarized choline molecular probe for monitoring acetylcholine synthesis.

  2011cites this paper
• Histone deacetylase inhibition increases levels of choline kinase alpha and phosphocholine facilitating non-invasive imaging in human cancers

  2011cites this paper
• The phosphoinositide 3-kinase inhibitor PI-103 downregulates choline kinase alpha leading to phosphocholine and total choline decrease detected by magnetic resonance spectroscopy.

  2010cites this paper
• Molecular mechanisms responsible for altered MRS choline profiles in cancer cells

  2010cites this paper
• Lipid profiling of cancerous and benign gallbladder tissues by 1H NMR spectroscopy

  2010cites this paper
• The Phosphoinositide 3-Kinase Inhibitor PI-103 Downregulates Choline Kinase α Leading to Phosphocholine and Total Choline Decrease Detected by Magnetic Resonance Spectroscopy

  2010cites this paper
• A selective NMR method for detecting choline containing compounds in liver tissue: the 1H-14N HSQC experiment.

  2010cites this paper
• Metabolic assessment of the action of targeted cancer therapeutics using magnetic resonance spectroscopy

  2009cites this paper